您使用提示模式 关闭
为了方块之间的快速移动

组织机构: Revvity
LEI 549300IKL1SDPFI7N655

机构名称
Revvity Inc
国家名称
美国
注册登记国
美国
行业
医疗设备
债券负债
3.994 百万 USD

探索最全面的数据库

80 万

债券

超过 400

定价来源

8 万

股票

9 千

ETF

以最有效的方式跟踪您的投资组合
债券筛选器
观察列表
Excel 附加组件

最新数据在

卖价

查询已发送
无法访问
信息提供者所提供的报价仅供参考。

简介

Revvity Inc is a provider of technology, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. Through the Company’s advanced technologies, solutions, and services, it addresses issues related to health and safety of people and their environment. It operates in two segments: Human Health and Environmental Health. In February 2011, it acquired chemagen Biopolymer-Technologie AG (chemagen). In March 2011, it acquired ArtusLabs, Inc. (ArtusLabs). In March 2011, it acquired specified assets and assumed specified liabilities of ID Biological Systems, Inc. (IDB). In April 2011, it acquired CambridgeSoft Corporation (CambridgeSoft). In May 2011, it acquired Geospiza, Inc. (Geospiza). In May 2011, it acquired Labtronics, Inc. (Labtronics). In June 2011, it acquired Dexela Limited (Dexela). In November 2011, it acquired Caliper Life Sciences, Inc. (Caliper).

奖项

相关文件

股票

最近一次的发行

债券负债 (按货币)

代码

  • LEI
    549300IKL1SDPFI7N655
  • SIC
    3826 LABORATORY ANALYTICAL INSTRUMENTS
  • ICB
    4.500 Health Care
  • CIK
    0000031791
  • EIN
    04-2052042

信用和 ESG 评级

宏观经济指数

你必须 注册 才能获得访问权